InDex Pharma
A stranger
UCRxF: A novel ulcerative colitis treatment A phase III ready feasibility study
INDEX PHARMACEUTICALS AB
processed a
H2020:
H2020-EIC-SMEInst-2018-2020
InDex Pharmaceuticals AB is a pharmaceutical development company based at the Karolinska Institutet Science Park in Stockholm, Sweden. The c...
2018-06-04 - 2018-08-31 | financed
2018-06-04 - 2018-08-31 | financed
* No data from the current company are not available.